🔎 Trials Near Me

Dachaigh › Cancer briste triple-negative › Ohio › Columbus

Sgrùdaidhean clionaigeach Cancer briste triple-negative ann an Columbus, OH

Tha 16 sgrùdaidhean airson Cancer briste triple-negative a’ lorg phàirtichean aig làraichean ann agus timcheall air Columbus (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

A’ fastadhÌre 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT05422794

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

A’ fastadhSgrùdadh amharc
  • The Ohio State University Comprehensive Cancer Center, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT04981119

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Local Institution - 0102, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06618287

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Ohio State University, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06657222

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

A’ fastadhÌre 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT03606967

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

A’ fastadhÌre 3
  • Ohio State University CRS, Columbus
  • Ohio Health Research Institute, Columbus
  • Anita Stewart Oncology Center, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT05633654

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

A’ fastadhÌre 1
  • The Ohio State University (OSU) Wexner Medical Center, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06400472

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • The Ohio State University, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Lùna 2026 · NCT05985655

SMP-3124LP in Adults With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Ohio State University, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT06526819

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

A’ fastadhÌre 1/2
  • Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT05579366

Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer

A’ fastadh
  • Ohio State University Comprehensive Cancer Center, Columbus
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 29 Ògmh 2026 · NCT05677802

A Study of LY4175408 in Participants With Advanced Cancer

A’ fastadhÌre 1
  • The Ohio State University (OSU) Wexner Medical Center, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT07046923

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

A’ fastadhÌre 2
  • The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT01042379

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

A’ fastadhÌre 2
  • Ohio State University Medical Center, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Gibl 2026 · NCT04468061

Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer

A’ fastadh
  • Ohio State University Comprehensive Cancer Center, Columbus
Aoisean 40 gu 65 · Banairean · Air ùrachadh 11 Dùbh 2025 · NCT06582615

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

A’ fastadhÌre 1/2
  • The Ohio State University, Columbus
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2025 · NCT06682793

Sgrùdaidhean Cancer briste triple-negative ann am bailtean eile

Sgrùdaidhean eile ann an Columbus

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.